Tazemetostat in combination with lenalidomide and rituximab in patients with relapsed/refractory follicular lymphoma: Phase 1b results of SYMPHONY-1 Meeting Abstract
| Authors: | Batlevi, C. L.; Salles, G.; Park, S. I.; Phillips, T. J.; Amengual, J. E.; Andorsky, D.; Campbell, P.; McKay, P.; Leonard, J. P.; Sondhi, M.; Chen, Y.; Slatcher, P. L.; Lin, R.; Szanto, A.; Abbadi, S.; Morschhauser, F. |
| Abstract Title: | Tazemetostat in combination with lenalidomide and rituximab in patients with relapsed/refractory follicular lymphoma: Phase 1b results of SYMPHONY-1 |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 2296 |
| End Page: | 2298 |
| Language: | English |
| ACCESSION: | WOS:000893223202129 |
| DOI: | 10.1182/blood-2022-166991 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work